Analyst firms · Jefferies · CHE
Jefferies CHE price target and rating history
Chemed Corp (CHE) · Health Care
Jefferies rates Chemed Corp (CHE) Buy with a $620 price target, as of its latest action on Oct 28, 2026. It has published 4 rating actions on CHE since July 2025, including 2 upgrades and 1 downgrade. Across 3 firms with a CHE price target in the last 12 months, the median target is $620. Jefferies's target matches it.
- Current rating
- Buy
- Price target
- $620
- Median target, all firms
- $620
- Actions on CHE
- 4
Jefferies price target on CHE
Every Jefferies rating on CHE
- Oct 28, 2026
- Jan 22, 2026
- Sep 2, 2025
- Jul 25, 2025
How other firms rate CHE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Buy | $620 | Oct 28, 2026 |
| UBS | Buy | $650 | Sep 25, 2026 |
| RBC Capital Markets | Sector Perform | $422 | Feb 27, 2026 |
Questions about Jefferies and CHE
- What is Jefferies's price target for CHE?
- Jefferies's latest stated price target for Chemed Corp (CHE) is $620, from its action on Oct 28, 2026.
- What is Jefferies's rating on CHE?
- Jefferies rates CHE Buy, a bullish rating, as of Oct 28, 2026.
- When did Jefferies last change its view on CHE?
- On Oct 28, 2026, Jefferies upgrades to Buy from Hold, price target $620.
- How does Jefferies's CHE target compare with other analysts?
- Across 3 firms with a CHE price target in the last 12 months, the median target is $620. Jefferies's target matches it.
More CHE rating histories
All Jefferies ratingsCHE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.